Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protalix BioTherapeutics (PLX) Income from Continuing Operations (2016 - 2025)

Protalix BioTherapeutics has reported Income from Continuing Operations over the past 16 years, most recently at 1102000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 1102000.0 for Q4 2025, down 109.77% from a year ago — trailing twelve months through Dec 2025 was 2143000.0 (down 127.77% YoY), and the annual figure for FY2025 was 2025000.0, down 126.24%.
  • Income from Continuing Operations for Q4 2025 was 1102000.0 at Protalix BioTherapeutics, down from 2414000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for PLX hit a ceiling of 19339000.0 in Q2 2023 and a floor of 18579000.0 in Q4 2023.
  • Median Income from Continuing Operations over the past 5 years was 3170500.0 (2022), compared with a mean of 2059300.0.
  • Biggest five-year swings in Income from Continuing Operations: crashed 2179.87% in 2021 and later soared 462.56% in 2023.
  • Protalix BioTherapeutics' Income from Continuing Operations stood at 6614000.0 in 2021, then soared by 51.47% to 3210000.0 in 2022, then plummeted by 478.79% to 18579000.0 in 2023, then soared by 160.7% to 11278000.0 in 2024, then plummeted by 109.77% to 1102000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 1102000.0 (Q4 2025), 2414000.0 (Q3 2025), and 164000.0 (Q2 2025) per Business Quant data.